What is the role of pharmacotherapy in tobacco cessation in patients with schizophrenia?
Els
Charl
C
Department of Psychiatry University of Alberta Edmonton.
D000279:Administration, Cutaneous; D006293:Health Promotion; D006801:Humans; D009538:Nicotine / Q000008:administration & dosage / Q000031:analogs & derivatives; D012559:Schizophrenia / Q000150:complications*; D016540:Smoking Cessation / Q000379:methods*; D014029:Tobacco Use Disorder / Q000150:complications* / Q000188:drug therapy / Q000628:therapy*
D009538:Nicotine